• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Quantum-Si Incorporated

    6/10/26 4:34:28 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials
    Get the next $QSI alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-39486
    Issuer: Quantum-Si Inc
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 452 Fifth Avenue, 21st Floor
    New York NEW YORK 10018
    Telephone number: 410-375-0050
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    warrant
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2026-06-10 By Katelin Rowe CDO Analyst
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $QSI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QSI

    DatePrice TargetRatingAnalyst
    2/7/2025$3.75Buy
    Alliance Global Partners
    12/8/2023$3.00Buy
    H.C. Wainwright
    9/25/2023$3.50 → $2.00Buy → Hold
    Canaccord Genuity
    10/20/2021$13.00Buy
    Canaccord Genuity
    More analyst ratings

    $QSI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Jafri Amir

    4 - Quantum-Si Inc (0001816431) (Issuer)

    5/20/26 4:05:29 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Director Makes Brigid

    4 - Quantum-Si Inc (0001816431) (Issuer)

    5/20/26 4:05:31 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Director Kenny John P.

    4 - Quantum-Si Inc (0001816431) (Issuer)

    5/20/26 4:05:27 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dowdy Paula bought $104,450 worth of shares (109,890 units at $0.95), increasing direct ownership by 69% to 269,107 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    3/9/26 6:01:13 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Director Kummeth Charles R. bought $459,800 worth of shares (500,000 units at $0.92), increasing direct ownership by 141% to 855,000 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    3/9/26 6:01:59 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Keyes Jeffry R. bought $43,465 worth of shares (50,000 units at $0.87), increasing direct ownership by 13% to 446,820 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    8/13/24 6:01:25 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    SEC Filings

    View All

    SEC Form 25-NSE filed by Quantum-Si Incorporated

    25-NSE - Quantum-Si Inc (0001816431) (Subject)

    6/10/26 4:34:28 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form SD filed by Quantum-Si Incorporated

    SD - Quantum-Si Inc (0001816431) (Filer)

    5/22/26 4:08:24 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Quantum-Si Inc (0001816431) (Filer)

    5/15/26 4:14:08 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the Compensation Committee of Quantum-Si's Board of Directors has granted 134,141 restricted stock units ("RSUs") to new employees under the Company's previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the "2023 Inducement Plan"). The RSUs were granted as an inducement material to the new employees becoming an employee of Quantum-Si in accordance with Nasdaq Listing Rule 5635(c)(4).The 2023 Inducement Plan is used exclusively for the grant of equity awards to in

    6/16/26 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a partnership with Cell Signaling Technology ("CST") to advance and validate next-generation protein sequencing and analysis of post-translational modifications ("PTM") on the Proteus™ single-molecule protein sequencing platform. The partnership will focus on integrating CST's PTM detection and immunoaffinity enrichment expertise with Quantum-Si's Proteus workflows to enable site-resolved detection and quantitation of proteins and PTMs for research applications. CST is a leading supplier of high-quality re

    6/10/26 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Announces the Expansion of the Proteus™ Roadshow

    Multi-City Roadshow is Driving Awareness of Proteus and Developing Customer Funnel for Commercial Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced the expansion of a roadshow designed to accelerate the education of the market on its Proteus platform and applications for protein sequencing. The roadshow includes information about the Proteus platform and application focus as well as data on applications for protein sequencing utilizing the Company's first-generation Platinum® Pro instrument. During the second quarter of 2026, the roads

    6/3/26 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Quantum-Si with a new price target

    Alliance Global Partners initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.75

    2/7/25 8:29:38 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    H.C. Wainwright initiated coverage on Quantum-Si with a new price target

    H.C. Wainwright initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.00

    12/8/23 7:55:31 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Quantum-Si from Buy to Hold and set a new price target of $2.00 from $3.50 previously

    9/25/23 9:04:14 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Leadership Updates

    Live Leadership Updates

    View All

    Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced the appointment of Charles ("Chuck") Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During Mr. Kummeth's tenure at Bio-Techne, he oversaw tremendous growth across all aspects of the business including annual revenue growth from $300M to over $1.1B, growth in the employee base from 800 to over 3,000, and the successful execution of 19 acquisitions, all while maintaining a 35% or better EBITDA level. Under Mr. Ku

    5/30/24 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321183506/en/Paula Dowdy (Photo: Business Wire) Ms. Dowdy currently serves on the Board of Directors for SPT Labtech, a world leading lab automation tools company based in the UK and is an advisor at EQT Life Sciences, one of Europe's leading investors targeting innovative

    3/21/24 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Introduces World's First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new distributor who will make the company's protein sequencing instrument, Platinum® available for the first time in Japan. TOMY Digital Biology Co., Ltd., a renowned importer and distributor with a rich history dating back to the 1950s, will distribute Quantum-Si's next-generation protein sequencer™ and associated consumables throughout Japan. "Working with Quantum-Si marks a pivotal moment for TOMY Digital Biology, aligning with our commitment to advancing life sciences. We're poised to empower Japanese researchers wit

    1/18/24 8:30:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Financials

    Live finance-specific insights

    View All

    Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones

    Successful sequencing on integrated Proteus instruments and continued progress toward amino acid coverage and overall launch capabilities Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced financial results for the first quarter ended March 31, 2026. Press Release Highlights Successful sequencing on integrated Proteus™ instruments Sequenced first customer samples on a Proteus prototype system Current developmental sequencing kit detects 17 amino acids Multiple customer posters, pre-prints and manuscripts released during the quarter

    5/7/26 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the first quarter 2026 on Thursday, May 7, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individua

    4/16/26 8:30:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results

    Releases List Price of Proteus™ Platform Reiterates Proteus Development Program On Track for Year End 2026 Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the fourth quarter and full year ended December 31, 2025. Press Release Highlights Reported fourth quarter revenue of $451,000 Reported on track development of the Proteus platform and related R&D programs to expand proteome coverage and enable broad PTM analysis capabilities Announced list price for Proteus of $425,000 Announced 2026 Financial Guidance

    3/3/26 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Quantum-Si Incorporated

    SC 13D/A - Quantum-Si Inc (0001816431) (Subject)

    9/17/24 4:24:56 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Quantum-Si Incorporated

    SC 13G/A - Quantum-Si Inc (0001816431) (Subject)

    6/28/24 5:16:32 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Quantum-Si Incorporated

    SC 13G - Quantum-Si Inc (0001816431) (Subject)

    2/13/24 9:41:18 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials